BSE Live
Dec 05, 16:01Prev. Close
1558.40
Open Price
1551.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:53Prev. Close
1559.90
Open Price
1545.70
Bid Price (Qty.)
1551.70 (17)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Eris Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 13.62 | 13.60 | 13.60 | 13.59 | 13.58 | |
| Total Share Capital | 13.62 | 13.60 | 13.60 | 13.59 | 13.58 | |
| Reserves and Surplus | 2,840.74 | 2,572.52 | 2,182.39 | 1,894.27 | 1,562.84 | |
| Total Reserves and Surplus | 2,840.74 | 2,572.52 | 2,182.39 | 1,894.27 | 1,562.84 | |
| Total Shareholders Funds | 2,854.36 | 2,586.12 | 2,195.99 | 1,907.86 | 1,576.42 | |
| Minority Interest | 417.40 | 635.91 | 24.69 | -0.11 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,737.51 | 654.51 | 644.45 | 45.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 518.45 | 542.82 | 257.64 | 46.09 | 49.54 | |
| Other Long Term Liabilities | 55.08 | 44.68 | 57.21 | 41.08 | 10.56 | |
| Long Term Provisions | 68.98 | 52.72 | 44.12 | 32.11 | 31.33 | |
| Total Non-Current Liabilities | 2,380.02 | 1,294.73 | 1,003.42 | 164.29 | 91.43 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 684.15 | 2,080.76 | 185.57 | 0.01 | 0.01 | |
| Trade Payables | 332.35 | 268.35 | 124.77 | 117.77 | 102.62 | |
| Other Current Liabilities | 286.80 | 120.92 | 63.46 | 42.80 | 36.82 | |
| Short Term Provisions | 78.09 | 62.05 | 69.44 | 39.06 | 27.49 | |
| Total Current Liabilities | 1,381.39 | 2,532.08 | 443.23 | 199.65 | 166.93 | |
| Total Capital And Liabilities | 7,033.17 | 7,048.84 | 3,667.33 | 2,272.14 | 1,834.78 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 662.07 | 504.60 | 356.00 | 167.85 | 77.88 | |
| Intangible Assets | 3,732.44 | 2,961.71 | 1,880.25 | 656.62 | 682.52 | |
| Capital Work-In-Progress | 66.74 | 19.06 | 21.38 | 24.00 | 0.00 | |
| Fixed Assets | 4,461.52 | 3,485.98 | 2,257.98 | 851.46 | 761.95 | |
| Non-Current Investments | 62.00 | 15.54 | 6.69 | 420.84 | 243.65 | |
| Deferred Tax Assets [Net] | 289.04 | 306.94 | 273.95 | 243.13 | 200.63 | |
| Long Term Loans And Advances | 1.08 | 1.04 | 0.96 | 2.82 | 4.95 | |
| Other Non-Current Assets | 84.57 | 76.05 | 31.18 | 33.08 | 63.08 | |
| Total Non-Current Assets | 5,810.18 | 4,746.77 | 2,902.61 | 1,644.81 | 1,367.73 | |
| CURRENT ASSETS | ||||||
| Current Investments | 5.00 | 0.00 | 30.01 | 99.55 | 50.40 | |
| Inventories | 334.83 | 189.03 | 131.44 | 117.91 | 94.47 | |
| Trade Receivables | 458.64 | 422.02 | 292.71 | 160.97 | 140.49 | |
| Cash And Cash Equivalents | 222.83 | 1,400.63 | 58.46 | 52.33 | 38.28 | |
| Short Term Loans And Advances | 5.77 | 5.56 | 3.99 | 23.00 | 3.34 | |
| OtherCurrentAssets | 195.92 | 284.83 | 248.13 | 173.57 | 140.08 | |
| Total Current Assets | 1,222.99 | 2,302.07 | 764.72 | 627.33 | 467.05 | |
| Total Assets | 7,033.17 | 7,048.84 | 3,667.33 | 2,272.14 | 1,834.78 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 68.01 | 1,510.02 | 31.23 | 27.40 | 19.60 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 13.44 | 13.44 | 13.44 | 13.44 | 13.44 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.33 | 5.33 | 0.33 | 0.35 | 0.36 | |
| Non-Current Investments Unquoted Book Value | 61.17 | 10.22 | 6.36 | 420.49 | 243.29 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 5.00 | 0.00 | 30.01 | 99.55 | 50.40 |
27.11.2025
Eris Life Standalone September 2025 Net Sales at Rs 650.50 crore, up 51.72% Y-o-Y
19.11.2025
Eris Life Consolidated September 2025 Net Sales at Rs 792.41 crore, up 7.23% Y-o-Y
12.11.2025
Eris Lifesciences net profit jumps 39 percent YoY to Rs 134 crore
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher